ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 716 filers reported holding ASTRAZENECA PLC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $58,091,627 | +19.5% | 857,821 | +26.3% | 0.04% | +34.4% |
Q2 2023 | $48,623,601 | -43.4% | 679,385 | -45.1% | 0.03% | -46.7% |
Q1 2023 | $85,895,239 | +31.7% | 1,237,505 | +28.6% | 0.06% | +15.4% |
Q4 2022 | $65,229,371 | +118.4% | 962,085 | +76.7% | 0.05% | +147.6% |
Q3 2022 | $29,862,000 | +13.1% | 544,559 | +36.3% | 0.02% | +10.5% |
Q2 2022 | $26,392,000 | -31.7% | 399,466 | -31.5% | 0.02% | -17.4% |
Q1 2022 | $38,660,000 | -20.2% | 582,741 | -29.9% | 0.02% | -14.8% |
Q4 2021 | $48,429,000 | -24.7% | 831,372 | -22.4% | 0.03% | -28.9% |
Q3 2021 | $64,339,000 | -91.1% | 1,071,258 | -91.2% | 0.04% | -91.3% |
Q2 2021 | $725,508,000 | +152.1% | 12,111,978 | +109.2% | 0.44% | +134.4% |
Q1 2021 | $287,832,000 | +54.6% | 5,789,075 | +55.5% | 0.19% | +69.1% |
Q4 2020 | $186,153,000 | +380.1% | 3,723,833 | +426.4% | 0.11% | +340.0% |
Q3 2020 | $38,770,000 | +26.8% | 707,459 | +22.4% | 0.02% | +4.2% |
Q2 2020 | $30,571,000 | -41.0% | 578,011 | -50.1% | 0.02% | -48.9% |
Q1 2020 | $51,776,000 | +96.2% | 1,159,334 | +119.1% | 0.05% | +147.4% |
Q4 2019 | $26,388,000 | +12.9% | 529,229 | +0.9% | 0.02% | 0.0% |
Q3 2019 | $23,366,000 | +23.6% | 524,252 | +14.4% | 0.02% | +18.8% |
Q2 2019 | $18,912,000 | +21.0% | 458,138 | +18.5% | 0.02% | +6.7% |
Q1 2019 | $15,634,000 | -44.3% | 386,711 | -47.7% | 0.02% | -48.3% |
Q4 2018 | $28,075,000 | +62.7% | 739,194 | +69.5% | 0.03% | +93.3% |
Q3 2018 | $17,258,000 | -18.5% | 436,141 | -27.7% | 0.02% | -21.1% |
Q2 2018 | $21,184,000 | -29.7% | 603,357 | -30.0% | 0.02% | -24.0% |
Q1 2018 | $30,148,000 | -24.9% | 862,122 | -25.4% | 0.02% | -24.2% |
Q4 2017 | $40,123,000 | +14.5% | 1,156,281 | +11.8% | 0.03% | +13.8% |
Q3 2017 | $35,047,000 | -4.3% | 1,034,466 | -3.7% | 0.03% | -12.1% |
Q2 2017 | $36,612,000 | +99.5% | 1,073,954 | +82.2% | 0.03% | +106.2% |
Q1 2017 | $18,354,000 | -29.2% | 589,455 | -37.9% | 0.02% | -30.4% |
Q4 2016 | $25,928,000 | +87.6% | 949,113 | +125.6% | 0.02% | +76.9% |
Q3 2016 | $13,823,000 | -23.3% | 420,664 | -29.5% | 0.01% | -27.8% |
Q2 2016 | $18,017,000 | +49.0% | 596,789 | +39.0% | 0.02% | +28.6% |
Q1 2016 | $12,092,000 | -21.6% | 429,361 | -5.5% | 0.01% | -12.5% |
Q4 2015 | $15,431,000 | +0.3% | 454,569 | -6.0% | 0.02% | +14.3% |
Q3 2015 | $15,385,000 | -38.2% | 483,509 | +23.8% | 0.01% | -36.4% |
Q2 2015 | $24,883,000 | +36.4% | 390,552 | +46.5% | 0.02% | +22.2% |
Q1 2015 | $18,241,000 | -58.9% | 266,541 | -57.7% | 0.02% | -53.8% |
Q4 2014 | $44,391,000 | -32.5% | 630,721 | -31.5% | 0.04% | -31.6% |
Q3 2014 | $65,772,000 | +14.9% | 920,657 | +19.5% | 0.06% | +3.6% |
Q2 2014 | $57,265,000 | +194.3% | 770,613 | +157.0% | 0.06% | +175.0% |
Q1 2014 | $19,456,000 | -36.6% | 299,869 | -42.0% | 0.02% | -28.6% |
Q4 2013 | $30,679,000 | +59.5% | 516,733 | +39.5% | 0.03% | +55.6% |
Q3 2013 | $19,233,000 | +10.8% | 370,350 | +1.0% | 0.02% | +12.5% |
Q2 2013 | $17,351,000 | – | 366,844 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |